152 related articles for article (PubMed ID: 27941878)
21. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
22. ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis.
Jin X; Li Y; Guo Y; Jia Y; Qu H; Lu Y; Song P; Zhang X; Shao Y; Qi D; Xu W; Quan C
Cell Prolif; 2019 Jul; 52(4):e12612. PubMed ID: 31012189
[TBL] [Abstract][Full Text] [Related]
23. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
[TBL] [Abstract][Full Text] [Related]
24. SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.
Wang Y; Zhou D; Phung S; Warden C; Rashid R; Chan N; Chen S
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1500-E1508. PubMed ID: 28174265
[TBL] [Abstract][Full Text] [Related]
25. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
26. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
27. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
28. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells.
Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q
Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.
Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H
Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
Cuesta R; Berman AY; Alayev A; Holz MK
J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
[TBL] [Abstract][Full Text] [Related]
32. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
33. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
34. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.
Mauro L; Pellegrino M; De Amicis F; Ricchio E; Giordano F; Rizza P; Catalano S; Bonofiglio D; Sisci D; Panno ML; Andò S
Cell Cycle; 2014; 13(4):553-64. PubMed ID: 24335340
[TBL] [Abstract][Full Text] [Related]
35. ERα-36 regulates progesterone receptor activity in breast cancer.
Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
[TBL] [Abstract][Full Text] [Related]
36. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
38. Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform.
Kammerer M; Gutzwiller S; Stauffer D; Delhon I; Seltenmeyer Y; Fournier B
Mol Cell Endocrinol; 2013 Apr; 369(1-2):150-60. PubMed ID: 23403054
[TBL] [Abstract][Full Text] [Related]
39. Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.
Chisamore MJ; Wilkinson HA; Flores O; Chen JD
Mol Cancer Ther; 2009 Mar; 8(3):672-81. PubMed ID: 19276159
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]